When men first learn that their testosterone levels are low, the conversation usually centres on how they feel right now: the fatigue, the low libido, the brain fog. And those symptoms matter. They affect your daily life, your relationships, and your sense of self. But there is another dimension to testosterone deficiency that receives far less attention, and it is arguably more important.
Testosterone is not just a sex hormone. It is a metabolic hormone, a cardiovascular hormone, a hormone that influences bone density, insulin sensitivity, body composition, and mental health. When levels remain low over months and years, the consequences extend well beyond feeling tired or losing interest in sex. They can quietly reshape your long-term health in ways that are serious, measurable, and in many cases, preventable.
This article explores the evidence behind those long-term risks. Not to frighten you, but to give you the information you need to make a properly informed decision about whether to act.
Why Low Testosterone Is So Often Dismissed
Before we examine the health consequences, it is worth understanding why low testosterone is so frequently overlooked as a medical concern. There are several reasons, and they tend to reinforce each other.
First, the symptoms are non-specific. Fatigue, weight gain, low mood, and reduced motivation can be caused by dozens of conditions. GPs across the UK, whether in Manchester, Belfast, Edinburgh, or Cardiff, are understandably cautious about attributing these common complaints to a single hormonal cause.
Second, there is a cultural tendency to normalise the decline. “You are just getting older” is a response that many men have heard from healthcare professionals, family members, and even themselves. And while ageing does involve some natural reduction in testosterone, this framing can discourage men from investigating whether their decline has crossed from normal into clinically significant territory.
Third, testosterone has an image problem. Decades of association with bodybuilding, performance enhancement, and exaggerated masculinity have made some clinicians and patients uncomfortable with the idea of testosterone as a legitimate medical treatment. This is unfortunate, because it means that a genuine and treatable deficiency is sometimes left unaddressed due to stigma rather than science.
The result is that many men live with low testosterone for years, adapting to a diminished baseline and never discovering that their symptoms have a measurable cause with established treatment options.
Cardiovascular Health and Low Testosterone
The relationship between testosterone and cardiovascular health is one of the most actively studied areas in men’s health, and the evidence has become increasingly clear: chronically low testosterone is associated with increased cardiovascular risk.
A large observational study published in the European Heart Journal found that men with low testosterone levels had a significantly higher risk of cardiovascular events compared to men with levels in the normal range. This association remained even after adjusting for conventional risk factors such as age, smoking, diabetes, and blood pressure.
There are several mechanisms through which low testosterone may affect the cardiovascular system. Testosterone plays a role in maintaining healthy endothelial function, which is the ability of blood vessels to dilate and contract appropriately. It influences lipid metabolism, helping to maintain a healthier ratio of HDL to LDL cholesterol. And it is involved in red blood cell production, which affects oxygen delivery throughout the body.
Low testosterone is also associated with increased arterial stiffness and higher levels of inflammatory markers, both of which are independent risk factors for heart disease and stroke.
This does not mean that low testosterone directly causes heart attacks. Cardiovascular disease is multifactorial, and testosterone is one piece of a complex puzzle. But it does mean that men with chronically low levels may be carrying an additional, modifiable risk factor that is being ignored.
Metabolic Syndrome, Insulin Resistance, and Type 2 Diabetes
The metabolic consequences of sustained low testosterone are substantial and well-documented. Testosterone deficiency is closely associated with metabolic syndrome, a cluster of conditions that includes abdominal obesity, elevated blood sugar, abnormal cholesterol levels, and high blood pressure. Together, these factors significantly increase the risk of developing type 2 diabetes and cardiovascular disease.
The relationship between testosterone and insulin sensitivity is particularly important. Testosterone helps the body respond effectively to insulin, the hormone that regulates blood sugar. When testosterone levels drop, insulin sensitivity can decrease, leading to higher blood sugar levels and, over time, an increased risk of type 2 diabetes.
Research published in Diabetes Care has shown that men with low testosterone are significantly more likely to develop type 2 diabetes than men with normal levels. The association is bidirectional: low testosterone promotes insulin resistance, and insulin resistance can further suppress testosterone production, creating a cycle that progressively worsens both conditions.
Visceral fat, the metabolically active fat that accumulates around the abdomen, is both a consequence and a driver of this process. Low testosterone promotes visceral fat accumulation, and visceral fat produces enzymes that convert testosterone to oestrogen, further depleting testosterone levels. Breaking this cycle often requires medical intervention alongside lifestyle changes.
Bone Density and Osteoporosis Risk
Osteoporosis in men is a significantly underappreciated health concern. While it is far more commonly discussed in the context of postmenopausal women, men account for approximately one-third of all hip fractures in the UK, and the mortality rate following hip fracture is higher in men than in women.
Testosterone plays a direct role in maintaining bone mineral density. It stimulates osteoblast activity, which is the process by which new bone is formed, and it helps regulate the balance between bone formation and bone resorption. When testosterone levels are chronically low, this balance shifts, and bone density gradually decreases.
The NICE guidelines on assessment of fracture risk recognise hypogonadism as a secondary cause of osteoporosis in men. Yet in practice, testosterone levels are rarely checked as part of bone health assessments, meaning that a treatable contributing factor may be missed.
The insidious nature of bone loss is that it produces no symptoms until a fracture occurs. By the time a man breaks a wrist, a vertebra, or a hip, the underlying bone density loss may have been progressing silently for years. Early identification and treatment of low testosterone can be an important preventive measure.
Mental Health: Depression, Anxiety, and Cognitive Decline
The mental health consequences of untreated low testosterone deserve particular attention because they are both significant and frequently misattributed.
There is consistent evidence that men with low testosterone have higher rates of depressive symptoms compared to men with normal levels. A meta-analysis published in JAMA Psychiatry found a significant association between low testosterone and depression in men, and several randomised controlled trials have demonstrated that testosterone replacement therapy can improve mood in men with confirmed deficiency.
This does not mean that every depressed man has low testosterone, or that testosterone is a substitute for established mental health treatments. But it does mean that for some men, particularly those whose depression has not responded well to conventional treatment, an undiagnosed hormonal deficiency may be a contributing factor.
Beyond mood, there is growing interest in the relationship between testosterone and cognitive function. Testosterone receptors are found in brain regions associated with memory, attention, and spatial processing. Some longitudinal studies have found associations between low testosterone and increased risk of cognitive decline, though this remains an active area of research and the evidence is not yet conclusive enough to draw firm causal links.
What is clear is that the lived experience of cognitive difficulty, whether or not it meets formal diagnostic criteria, is real for many men with low testosterone. The brain fog, the difficulty concentrating, the sense that your mental sharpness has diminished: these are not imaginary, and they have a measurable biochemical basis.
Impact on Body Composition and Physical Function
The changes in body composition associated with low testosterone, specifically the loss of lean muscle mass and the gain of fat mass, are not merely cosmetic concerns. They have direct implications for physical function, metabolic health, and quality of life.
Muscle mass is metabolically active tissue. It helps regulate blood sugar, supports joint function, protects against falls and fractures, and contributes to overall functional independence as men age. When testosterone levels decline and muscle mass follows, the consequences compound over time. Less muscle means a lower metabolic rate, which promotes further fat gain, which further suppresses testosterone, which accelerates muscle loss. The trajectory is unfavourable, and it becomes harder to reverse the longer it continues.
For men in their 40s, 50s, and beyond, maintaining muscle mass is not about aesthetics. It is about maintaining the physical capacity to live well, to remain active, and to reduce the risk of age-related disability. Low testosterone undermines that capacity in a measurable and progressive way.
Quality of Life: The Cost of Doing Nothing
Medical discussions about low testosterone tend to focus on disease risk, and rightly so. But there is another cost that is harder to quantify but no less real: the erosion of quality of life.
Men with untreated low testosterone often describe a gradual narrowing of their world. They have less energy, so they do less. They feel less motivated, so they disengage from hobbies, friendships, and goals. Their relationships suffer because of reduced libido, irritability, or emotional withdrawal. They gain weight, which affects their confidence and further reduces their activity levels. Over time, the man they used to be starts to feel like a memory.
This is not melodrama. It is the consistent lived experience reported by men with clinically low testosterone. And the reason it matters in a discussion about danger is that quality of life is a legitimate health outcome. A life lived at half capacity, even in the absence of a diagnosed disease, represents a real and meaningful loss.
When Does Low Testosterone Become a Medical Concern?
Not every man with slightly below-average testosterone needs treatment. The body has considerable resilience, and modest fluctuations in hormone levels are normal. Low testosterone becomes a genuine medical concern when two conditions are met:
- Blood tests confirm levels that are clearly below the reference range, ideally on at least two morning samples taken on separate days
- The man is experiencing symptoms that are consistent with testosterone deficiency and that are affecting his quality of life or health
Both elements matter. A low number without symptoms may warrant monitoring but not necessarily treatment. Symptoms without a confirmatory blood test could have another cause entirely. It is the combination of objective measurement and subjective experience that defines clinically significant testosterone deficiency.
In the UK, the typical reference range for total testosterone is approximately 8.64 to 29 nmol/L, though this varies between laboratories. The NHS generally considers levels below 8 nmol/L as clearly low, with levels between 8 and 12 nmol/L representing a borderline zone where clinical judgement and symptom assessment become particularly important.
The Importance of Not Ignoring Symptoms
Perhaps the most dangerous aspect of low testosterone is not any single health risk, but the tendency to accept it as normal. Men are culturally conditioned to endure, to push through, and to avoid seeking medical help unless something is obviously wrong. Low testosterone is rarely obvious. It is subtle, gradual, and easy to rationalise.
But the evidence is clear: sustained testosterone deficiency carries real health risks, from cardiovascular disease and diabetes to osteoporosis and mental health deterioration. These are not theoretical concerns. They are documented consequences of a treatable condition.
If you have been experiencing symptoms that might be related to low testosterone, whether you are in London, Glasgow, Belfast, or anywhere else in the UK, the responsible course of action is to find out. A blood test is simple. A clinical conversation is straightforward. And the potential benefit, catching a treatable deficiency before it causes lasting harm, is substantial.
At Evernu, we provide comprehensive testosterone assessments that combine blood testing with thorough symptom evaluation. We are RQIA-regulated and committed to evidence-based care. Our clinicians will not push treatment where it is not needed, but they will not dismiss your concerns either. If something is wrong, we will help you understand what it is and what your options are.
You do not have to accept feeling this way. And you certainly should not ignore it. Start your assessment today and take the first step towards understanding what your body is telling you.
Frequently Asked Questions About the Dangers of Low Testosterone
Can untreated low testosterone shorten your life?
Several large observational studies have found an association between chronically low testosterone levels and increased all-cause mortality in men. This does not mean that low testosterone directly causes premature death, but it does suggest that the cumulative health effects of sustained deficiency, including increased cardiovascular risk, metabolic syndrome, and reduced physical function, can contribute to worse overall health outcomes. The evidence is strong enough to take seriously, particularly when the condition is treatable.
Is it safe to leave low testosterone untreated if I feel fine?
If your testosterone levels are low but you genuinely have no symptoms, your clinician may recommend monitoring rather than immediate treatment. However, it is worth remembering that many of the long-term consequences of low testosterone, such as reduced bone density and metabolic changes, can develop silently before symptoms become apparent. Regular monitoring and a thorough assessment of both symptoms and objective health markers are important.
Does low testosterone increase the risk of heart disease?
Yes, there is consistent evidence linking low testosterone to increased cardiovascular risk. This includes associations with higher rates of arterial stiffness, unfavourable cholesterol profiles, and increased inflammatory markers. Multiple large-scale studies have found that men with low testosterone have higher rates of cardiovascular events compared to men with normal levels. However, cardiovascular disease is complex and multifactorial, so testosterone is one contributing factor among many.
Can low testosterone cause type 2 diabetes?
Low testosterone is strongly associated with insulin resistance and an increased risk of developing type 2 diabetes. The relationship is bidirectional: low testosterone promotes insulin resistance and fat accumulation, which in turn further suppresses testosterone production. Men with testosterone deficiency are significantly more likely to develop type 2 diabetes compared to men with normal levels, and treating the deficiency can, in some cases, improve insulin sensitivity.
Why do some doctors not take low testosterone seriously?
There are several reasons. The symptoms of low testosterone overlap with many other conditions, making it easy to attribute them to stress, ageing, or depression. Some clinicians remain cautious due to historical concerns about testosterone therapy and prostate cancer risk, though the evidence on this has evolved significantly. Additionally, testosterone has cultural associations with performance enhancement that can create reluctance in clinical settings. The result is that many men with genuine deficiency face barriers to diagnosis and treatment. Specialist services like Evernu exist in part to address this gap in care.
